نتائج البحث - Duvaraka Kula‐Alwar
- يعرض 1 - 5 نتائج من 5
-
1
Targeting Succinate Metabolism in Ischemia/Reperfusion Injury حسب Duvaraka Kula‐Alwar, Hiran A. Prag, Thomas Krieg
منشور في 2019Revisão -
2
Structural basis for a complex I mutation that blocks pathological ROS production حسب Zhan Yin, Nils Burger, Duvaraka Kula‐Alwar, Dunja Aksentijević, Hannah R. Bridges, Hiran A. Prag, Daniel N. Grba, Carlo Viscomi, Andrew M. James, Amin Mottahedin, Thomas Krieg, Michael P. Murphy, Judy Hirst
منشور في 2021Artigo -
3
Cardiac metabolism as a driver and therapeutic target of myocardial infarction حسب Coert J. Zuurbier, Luc Bertrand, Christoph R. Beauloye, Ioanna Andreadou, Marisol Ruiz‐Meana, Nichlas Riise Jespersen, Duvaraka Kula‐Alwar, Hiran A. Prag, Hans Eric Botker, Maija Dambrova, Christophe Montessuit, Tuuli Käämbre, Edgars Liepinsh, Paul S. Brookes, Thomas Krieg
منشور في 2020Revisão -
4
Ischemia-Selective Cardioprotection by Malonate for Ischemia/Reperfusion Injury حسب Hiran A. Prag, Dunja Aksentijević, Andreas Dannhorn, Abigail V. Giles, John F. Mulvey, Olga Sauchanka, Luping Du, Georgina Bates, Johannes Reinhold, Duvaraka Kula‐Alwar, Zhelong Xu, Luc Pellerin, Richard J. A. Goodwin, Michael P. Murphy, Thomas Krieg
منشور في 2022Artigo -
5
Ester Prodrugs of Malonate with Enhanced Intracellular Delivery Protect Against Cardiac Ischemia-Reperfusion Injury In Vivo حسب Hiran A. Prag, Laura Pala, Duvaraka Kula‐Alwar, John F. Mulvey, Luping Du, Timothy E. Beach, Lee M. Booty, Andrew Hall, Angela Logan, Volha Sauchanka, Stuart T. Caldwell, Ellen L. Robb, Andrew M. James, Zhelong Xu, Kourosh Saeb‐Parsy, Richard C. Hartley, Michael P. Murphy, Thomas Krieg
منشور في 2020Artigo
أدوات البحث:
موضوعات ذات صلة
Internal medicine
Medicine
Biochemistry
Biology
Chemistry
Ischemia
Pharmacology
Reperfusion injury
Anesthesia
Biotechnology
Cardiology
In vivo
Malonate
Metabolism
Mitochondrion
Reactive oxygen species
Cell biology
Gene
Mitochondrial DNA
Mutant
Mutation
Myocardial infarction
Myocyte
Oxidative phosphorylation
Phosphorylation
Point mutation
Prodrug